These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 30414981)

  • 1. Molecular biomarkers of Graves' ophthalmopathy.
    Longo CM; Higgins PJ
    Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.
    Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV
    J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
    Wu SB; Hou TY; Kau HC; Tsai CC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves' Ophthalmopathy.
    Chiu HI; Wu SB; Tsai CC
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Suppresses TGF-β1-Induced Myofibroblast Differentiation and Attenuates Angiogenic Activity of Orbital Fibroblasts.
    Yu WK; Hwang WL; Wang YC; Tsai CC; Wei YH
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.
    Tsai CC; Wu SB; Kau HC; Wei YH
    Sci Rep; 2018 May; 8(1):7276. PubMed ID: 29739987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
    Park M; Banga JP; Kim GJ; Kim M; Lew H
    Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
    Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
    Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.
    Pawlowski P; Poplawska I; Mysliwiec J; Dik WA; Eckstein A; Berchner-Pfannschmidt U; Milewski R; Lawicki S; Dzieciol-Anikiej Z; Rejdak R; Reszec J
    Folia Histochem Cytobiol; 2020; 58(1):37-45. PubMed ID: 32176314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
    Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
    Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
    [No Abstract]   [Full Text] [Related]  

  • 14. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
    Ekronarongchai S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
    Thyroid; 2021 Oct; 31(10):1566-1576. PubMed ID: 34235979
    [No Abstract]   [Full Text] [Related]  

  • 15. A Review of Pathophysiology and Therapeutic Strategies Targeting TGF-β in Graves' Ophthalmopathy.
    Chang HH; Wu SB; Tsai CC
    Cells; 2024 Sep; 13(17):. PubMed ID: 39273063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
    Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
    Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
    Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
    Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kau HC; Wu SB; Tsai CC; Liu CJ; Wei YH
    Oxid Med Cell Longev; 2016; 2016():4676289. PubMed ID: 27340508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
    Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
    Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.